Engineering AAV receptor footprints for gene therapy

Current Opinion in Virology

Volumn 18, Issue , 2016, Pages 89-96

  Madigan, Victoria J ^a,b   Asokan, Aravind ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS RECEPTOR; GLYCAN; RECEPTOR; UNCLASSIFIED DRUG; CAPSID PROTEIN; POLYSACCHARIDE; VIRUS RECEPTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 5; ADENO ASSOCIATED VIRUS 6; ADENO ASSOCIATED VIRUS 9; ARTICLE; BIOENGINEERING; CHEMICAL INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE THERAPY; VIRUS CAPSID; CHEMISTRY; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; PROCEDURES;

CAPSID; CAPSID PROTEINS; DEPENDOVIRUS; GENETIC ENGINEERING; GENETIC THERAPY; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; POLYSACCHARIDES; RECEPTORS, VIRUS;

EID: 84971393430     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2016.05.001     Document Type: Review

References (59)

1. R.W. Atchison, B.C. Casto, and M. Hammon Adenovirus-associated defective virus particles Science 49 1965 754 756
2. B.J. Carter Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective Mol Ther 10 2004 981 989
3. N. Alazard-Dany, A. Nicolas, A. Ploquin, R. Strasser, A. Greco, A.L. Epstein, C. Fraefel, and A. Salvetti Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events PLoS Pathog 5 2009 e1000340
4. M.C. Geoffroy, and A. Salvetti Helper functions required for wild type and recombinant adeno-associated virus growth Curr Gene Ther 5 2005 265 271
5. M. Agbandje-McKenna, and J. Kleinschmidt AAV capsid structure and cell interactions R. Snyder, P. Moullier, Adeno-associated Virus: Methods and Protocols 2011 Humana Press 47 92
6. Z. Wu, A. Asokan, and R.J. Samulski Adeno-associated virus serotypes: vector toolkit for human gene therapy Mol Ther 14 2006 316 327
7. K. Van Vliet, V. Blouin, N. Brument, M. Agbandje-Mckenna, and R. Snyder The role of the adeno-associated virus capsid in gene transfer K. Jain, Methods in Molecular Biology, Vol. 437: Drug Delivery Systems 2008 Humana Press 51 90
8. M. Salganik, M.L. Hirsch, and R.J. Samulski Adeno-associated virus as a mammalian DNA vector Microbiol Spectr 3 2015
9. D. Grimm, and S. Zolotukhin E Pluribus Unum: 50 years of research, millions of viruses, and one goal - tailored acceleration of AAV evolution Mol Ther 23 2015 1819 1831
10. E. Hastie, and R.J. Samulski Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success - a personal perspective Hum Gene Ther 26 2015 257 265
11. S. Mori, L. Wang, T. Takeuchi, and T. Kanda Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein Virology 330 2004 375 383
12. M. Schmidt, A. Voutetakis, S. Afione, C. Zheng, D. Mandikian, and J.A. Chiorini Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid-independent and heparan sulfate proteoglycan-independent transduction activity J Virol 82 2008 1399 1406
13. I. Bossis, and J.A. Chiorini Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles J Virol 77 2003 6799 6810
14. A. Bello, K. Tran, A. Chand, M. Doria, M. Allocca, M. Hildinger, D. Beniac, C. Kranendonk, A. Auricchio, and G.P. Kobinger Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues Gene Ther 16 2009 1320 1328 30
15. L.J. Ströh, and T. Stehle Glycan engagement by viruses: receptor switches and specificity Annu Rev Virol 1 2014 285 306
16. Z. Wu, E. Miller, M. Agbandje-mckenna, and R.J. Samulski α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6 J Virol 80 2006 9093 9103
17. S. Shen, K.D. Bryant, S.M. Brown, S.H. Randell, and A. Asokan Terminal N-linked galactose is the primary receptor for adeno-associated virus 9 J Biol Chem 286 2011 13532 13540
18. N. Kaludov, K.E. Brown, R.W. Walters, J. Zabner, and J.A. Chiorini Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity J Virol 75 2001 6884 6893
19. R.W. Walters, S. Min, P. Yi, S. Keshavjee, K.E. Brown, M.J. Welsh, J.A. Chiorini, and J. Zabner Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer J Biol Chem 276 2001 20610 20616
20. R. Ng, L. Govindasamy, B.L. Gurda, R. Mckenna, O.G. Kozyreva, R.J. Samulski, K.N. Parent, T.S. Baker, and M. Agbandje-Mckenna Structural characterization of the dual glycan binding adeno-associated virus serotype 6 J Virol 84 2010 12945 12957
21. K. Quinn, M.R. Quirion, C. Lo, J.A. Misplon, S.L. Epstein, and J.A. Chiorini Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune response Mol Ther 19 2009 1990 1998
22. M.A. Kotterman, and D.V. Schaffer Engineering adeno-associated viruses for clinical gene therapy Nat Rev Genet 15 2014 445 451
23. K. Adachi, T. Enoki, Y. Kawano, M. Veraz, and H. Nakai Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing Nat Commun 5 2014 1 14
24. L.E. Mays, and J.M. Wilson The complex and evolving story of T cell activation to AAV vector-encoded transgene products Mol Ther 19 2009 16 27
25. C. Ling, Y. Lu, J.K. Kalsi, G.R. Jayandharan, B. Li, W. Ma, B. Cheng, S.W. Gee, K.E. McGoogan, L. Govindasamy, and et al. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3 Hum Gene Ther 21 2010 1741 1747
26. Y. Kashiwakura, K. Tamayose, K. Iwabuchi, Y. Hirai, T. Shimada, K. Matsumoto, T. Nakamura, M. Watanabe, K. Oshimi, and H. Daida Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection J Virol 79 2005 609 614
27. M.L. Weller, P. Amornphimoltham, M. Schmidt, P.A. Wilson, J.S. Gutkind, and J. Chiorini A. Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6 Nat Med 16 2010 662 664
28. G. Di Pasquale, B.L. Davidson, C.S. Stein, I. Martins, D. Scudiero, A. Monks, and J.A. Chiorini Identification of PDGFR as a receptor for AAV-5 transduction Nat Med 9 2003 1306 1312
29. C. Summerford, J.S. Bartlett, and R.J. Samulski AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection Nat Med 5 1999 78 82
30. A. Asokan, J.B. Hamra, L. Govindasamy, M. Agbandje-McKenna, and R.J. Samulski Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry J Virol 80 2006 8961 8969
31. P.M. Kaminsky, N.W. Keiser, Z. Yan, D.C. Lei-Butters, and J.F. Engelhardt Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction Mol Ther 20 2012 972 983
32. S. Shen, G.E. Berry, R.M. Castellanos Rivera, R.Y. Cheung, A.N. Troupes, S.M. Brown, T. Kafri, and A. Asokan Functional analysis of the putative integrin recognition motif on adeno-associated virus 9 J Biol Chem 290 2015 1496 1504
33. S. Pillay, N.L. Meyer, A.S. Puschnik, O. Davulcu, J. Diep, Y. Ishikawa, L.T. Jae, J.E. Wosen, C.M. Nagamine, M.S. Chapman, and J.E. Carette An essential receptor for adeno-associated virus infection Nature 530 2016 108 112
34. L. Huang, S. Halder, and M. Agbandje-mckenna Parvovirus glycan interactions Curr Opin Virol 7 2014 108 118
35. N. Diprimio, A. Asokan, L. Govindasamy, M. Agbandje-mckenna, and R.J. Samulski Surface loop dynamics in adeno-associated virus capsid assembly J Virol 82 2008 5178 5189
36. S.R. Opie, K.H. Warrington, M. Agbandje-McKenna, S. Zolotukhin, and N. Muzyczka Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding J Virol 77 2003 6995 7006
37. A. Kern, K. Schmidt, C. Leder, O.J. Müller, C.E. Wobus, K. Bettinger, C.W. Von der Lieth, J.A. King, and J.A. Kleinschmidt Identification of a heparin-binding motif on adeno-associated virus type 2 capsids J Virol 77 2003 11072 11081
38. Q. Xie, W. Bu, S. Bhatia, J. Hare, T. Somasundaram, A. Azzi, and M.S. Chapman The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy Proc Natl Acad Sci 99 2002 10405 10410
39. H.C. Levy, V.D. Bowman, L. Govindasamy, R. McKenna, K. Nash, K. Warrington, W. Chen, N. Muzyczka, X. Yan, T.S. Baker, and M. Agbandje-McKenna Heparin binding induces conformational changes in Adeno-associated virus serotype 2 J Struct Biol 165 2009 146 156
40. T.F. Lerch, and M.S. Chapman Identification of the heparin binding site on adeno-associated virus serotype 3b (AAV-3B) Virology 423 2012 6 13
41. M. Schmidt, L. Govindasamy, S. Afione, N. Kaludov, M. Agbandje-mckenna, and J.A. Chiorini Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV (VR-942) J Virol 82 2008 8911 8916
42. Q. Xie, T.F. Lerch, N.L. Meyer, and M.S. Chapman Structure function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6) J Virol 420 2011 10 19
43. J.O. Donnell, K.A. Taylor, and M.S. Chapman Adeno-associated virus-2 and its primary cellular receptor-Cryo-EM structure of a heparin complex Virology 385 2009 434 443
44. F. Zhang, J. Aguilera, J.M. Beaudet, Q. Xie, T.F. Lerch, O. Davulcu, W. Colon, and M.S.R.L. Chapman Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus Biochemistry 52 2013 6275 6285
45. Z. Wu, A. Asokan, J.C. Grieger, L. Govindasamy, M. Agbandje-mckenna, and R.J. Samulski Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes J Virol 80 2006 11393 11397
46. T.F. Lerch, Q. Xie, and M.S. Chapman The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion Virology 403 2010 26 36
47. S. Shen, A.N. Troupes, N. Pulicherla, and A. Aravind Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4 J Virol 87 2013 13206 13213
48. L. Govindasamy, M.A. Dimattia, B.L. Gurda, S. Halder, R. Mckenna, and J.A. Chiorini Structural insights into adeno-associated virus serotype 5 J Virol 87 2013 11187 11199
49. S. Afione, M.A. Dimattia, S. Halder, G.Di Pasquale, M. Agbandje-mckenna, and J.A. Chiorini Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region J Virol 89 2015 1660 1672
50. M.A. Dimattia, H. Nam, K.Van Vliet, M. Mitchell, A. Bennett, B.L. Gurda, R. Mckenna, N.H. Olson, R.S. Sinkovits, M. Potter, and et al. Structural insight into the unique properties of adeno-associated virus serotype 9 J Virol 86 2012 6947 6958
51. C.L. Bell, B.L. Gurda, K.Van Vliet, M. Agbandje-mckenna, and J.M. Wilson Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid J Virol 86 2012 7326 7333
52. N. Pulicherla, S. Shen, S. Yadav, K. Debbink, L. Govindasamy, M. Agbandje-mckenna, and A. Asokan Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer Mol Ther 19 2009 1070 1078
53. S. Shen, K.D. Bryant, J. Sun, S.M. Brown, A. Troupes, N. Pulicherla, and A. Asokan Glycan binding avidity determines the systemic fate of adeno-associated virus type 9 J Virol 86 2012 10408 10417
54. S. Shen, E.D. Horowitz, A.N. Troupes, S.M. Brown, N. Pulicherla, R.J. Samulski, M. Agbandje-McKenna, and A. Asokan Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency J Biol Chem 288 2013 28814 28823
55. A. Asokan, J.C. Conway, J.L. Phillips, C. Li, J. Hegge, R. Sinnott, S. Yadav, N. Diprimio, H. Nam, M. Agbandje-mckenna, and et al. Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle Nat Biotechnol 28 2009 79 82
56. I.L. Rotundo, A. Lancioni, M. Savarese, L.D. Orsi, M. Iacomino, G. Nigro, G. Piluso, A. Auricchio, and V. Nigro Use of a lower dosage liver-detargeted AAV vector to prevent hamster muscular dystrophy Hum Gene Ther 430 2013 424 430
57. G. Murlidharan, T. Corriher, H.T. Ghashghaei, and A. Asokan Unique glycan signatures regulate adeno-associated virus tropism in the developing brain J Virol 89 2015 3976 3987
58. S.L. Boye, A. Bennett, M.L. Scalabrino, K.T. Mccullough, K.Van Vliet, S. Choudhury, Q. Ruan, J. Peterson, M. Agbandje-mckenna, and S.E. Boye Impact of heparan sulfate binding on transduction of retina by recombinant adeno-associated virus vectors J Virol 90 2016 4215 4231
59. C. Xiao, and M.G. Rossmann Interpretation of electron density with stereographic roadmap projections J Struct Biol 158 2007 182 187